E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/24/2012 in the Prospect News PIPE Daily.

Accelpath settles $100,000 private placement of 5% convertible notes

Promissory note due Jan. 31, 2013 sold to Southridge Partners in deal

By Devika Patel

Knoxville, Tenn., July 24 - Accelpath Inc. sold a $100,000 convertible promissory note to Southridge Partners II, LP on July 18, according to an 8-K filed Tuesday with the Securities and Exchange Commission.

The 5% note is due on Jan. 31, 2013 and is convertible into common shares at $0.0075 per share, which is a 25% discount to the July 17 closing share price of $0.01.

Based in Gaithersburg, Md., Accelpath helps in-office histology laboratories and hospitals enhance patient care by delivering digital pathology slides to leading sub-specialized, U.S. board-certified pathologists for interpretation.

Issuer:Accelpath Inc.
Issue:Convertible promissory note
Amount:$100,000
Maturity:Jan. 31, 2013
Coupon:5%
Conversion price:$0.0075
Warrants:No
Investor:Southridge Partners II, LP
Settlement date:July 18
Stock symbol:OTCBB: ACLP
Stock price:$0.01 at close July 17

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.